Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDITA: Methoxyflurane for Acute Trauma Pain
NCT03585374Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Feb 2018
- Primary completion
- Feb 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of methoxyflurane in Acute traumatic pain, sponsored by Mundipharma. Started Feb 2018; status: completed.
02
Drugs
methoxyflurane
03
Conditions
Acute traumatic pain
Beyond the preview
Go deeper on NCT03585374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585374.